Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

478 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis.
Arnold MB, Khanna D, Denton CP, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Riemekasten G, Steen V, Müller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE, Pope JE. Arnold MB, et al. Among authors: pope je. Rheumatology (Oxford). 2018 Jan 1;57(1):152-157. doi: 10.1093/rheumatology/kex396. Rheumatology (Oxford). 2018. PMID: 29077900 Free PMC article. Clinical Trial.
Increased pigmentation in scleroderma.
Pope JE, Shum DT, Gottschalk R, Stevens A, McManus R. Pope JE, et al. J Rheumatol. 1996 Nov;23(11):1912-6. J Rheumatol. 1996. PMID: 8923365
Treatment of systemic sclerosis.
Pope JE. Pope JE. Rheum Dis Clin North Am. 1996 Nov;22(4):893-907. doi: 10.1016/s0889-857x(05)70307-0. Rheum Dis Clin North Am. 1996. PMID: 8923602 Review.
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, Smith CD, Chalmers IM, Hong P, O'Hanlon D, Kaminska E, Markland J, Sibley J, Catoggio L, Furst DE. Pope JE, et al. Arthritis Rheum. 2001 Jun;44(6):1351-8. doi: 10.1002/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I. Arthritis Rheum. 2001. PMID: 11407694 Free article. Clinical Trial.
The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.
Sultan N, Pope JE, Clements PJ; Scleroderma Trials Study Group. Sultan N, et al. Among authors: pope je. Rheumatology (Oxford). 2004 Apr;43(4):472-8. doi: 10.1093/rheumatology/keh070. Epub 2003 Dec 16. Rheumatology (Oxford). 2004. PMID: 14679295 Clinical Trial.
Office capillaroscopy in systemic sclerosis.
Baron M, Bell M, Bookman A, Buchignani M, Dunne J, Hudson M, Jerome D, Johnson SR, Jones N, Kaminska E, Lupton T, Mathieu JP, Pope J, Steele R, Taillefer S. Baron M, et al. Clin Rheumatol. 2007 Aug;26(8):1268-74. doi: 10.1007/s10067-006-0489-6. Epub 2006 Dec 9. Clin Rheumatol. 2007. PMID: 17160528 Clinical Trial.
478 results